BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ang C, Doyle E, Branch A. Bisphosphonates as potential adjuvants for patients with cancers of the digestive system. World J Gastroenterol 2016; 22(3): 906-916 [PMID: 26811636 DOI: 10.3748/wjg.v22.i3.906]
URL: https://www.wjgnet.com/1007-9327/full/v22/i3/906.htm
Number Citing Articles
1
Dan-Ting Wen, Zheng Xu, Mei-Ling Xuan, Guo-Rong Liang, Wei-Ling Zheng, Xue-Fang Liang, Jing Xiao, Xiao-Yun Wang. Prognostic Effect of Bisphosphonate Exposure for Patients With Diagnosed Solid Cancer: A Systematic Review With Meta-Analysis of Observational StudiesFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00495
2
Zhiwei Shao, Haoqi Pan, Sheng Tu, Jingying Zhang, Sheng Yan, Anwen Shao. HGF/c-Met Axis: The Advanced Development in Digestive System CancerFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00801
3
Nabil A. Alhakamy, Osama A. A. Ahmed, Usama A. Fahmy, Shadab Md. Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic CancerPharmaceuticals 2021; 14(8): 729 doi: 10.3390/ph14080729
4
Zhengchao Zhang, Dong Li, Heng Yun, Jie Tong, Wei Liu, Keqiang Chai, Tongwei Zeng, Zhenghua Gao, Yongqiang Xie. Opportunities and challenges of targeting c-Met in the treatment of digestive tumorsFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.923260
5
Zintle Mbese, Blessing A. Aderibigbe. Bisphosphonate-Based Conjugates and Derivatives as Potential Therapeutic Agents in Osteoporosis, Bone Cancer and Metastatic Bone CancerInternational Journal of Molecular Sciences 2021; 22(13): 6869 doi: 10.3390/ijms22136869
6
A M Osadchuk, I L Davydkin, T A Gricenko, M A Osadchuk. Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problemTerapevticheskii arkhiv 2019; 91(8): 135 doi: 10.26442/00403660.2019.08.000228
7
Yini Ma, Xiu Cao, Guojuan Shi , Tianlu Shi. MiRNA-145 and Its Direct Downstream Targets in Digestive System Cancers: A Promising Therapeutic TargetCurrent Pharmaceutical Design 2021; 27(19): 2264 doi: 10.2174/1381612826666201029095702
8
Xian-Bin Cheng, Bo Fu, Xing-Zhao Li, Yang Jiang. Prognostic value of long non-coding RNA ATB in digestive system cancers: A meta-analysisPathology - Research and Practice 2020; 216(6): 152949 doi: 10.1016/j.prp.2020.152949
9
Dragana Bjelić, Matjaž Finšgar. Bioactive coatings with anti-osteoclast therapeutic agents for bone implants: Enhanced compliance and prolonged implant lifePharmacological Research 2022; 176: 106060 doi: 10.1016/j.phrs.2022.106060
10
Lin Chen, Zhicheng Dai, Huangrong Song, Jiafeng Zhang, Tuo Li. Disproportionality analysis of oesophageal toxicity associated with oral bisphosphonates using the FAERS database (2004–2023)Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1473756
11
Hongli Zhang, Qingqing Feng, Wei-Dong Chen, Yan-Dong Wang. HGF/c-MET: A Promising Therapeutic Target in the Digestive System CancersInternational Journal of Molecular Sciences 2018; 19(11): 3295 doi: 10.3390/ijms19113295
12
Ashraf Bahi el-din Abd, Usama Ahmed Fahmy. Alendronate Sodium Combined Glatiramer Acetate Nanocomplex Suppresses Pancreatic Cancer Cell GrowthInternational Journal of Pharmacology 2024; 20(7): 1281 doi: 10.3923/ijp.2024.1281.1291
13
Hai-Jun Wang, Yu Liu, Bao-Jun Zhou, Zhan-Xue Zhang, Ai-Ying Li, Ran An, Bin Yue, Li-Qiao Fan, Yong Li. Inhibitory effects of CP on the growth of human gastric adenocarcinoma BGC-823 tumours in nude miceJournal of International Medical Research 2018; 46(5): 1756 doi: 10.1177/0300060518761505